As a global pharmaceutical company with a biotech mindset and a proven ability to provide new, life-changing therapies, Ipsen is a leading player in its core therapeutic areas.

Ipsen : 2018 financial objectives

Specialty Care Sales

>24%

Consumer Healthcare sales

Back to growth

Core operating margin

>25%

Ipsen : H1 2017 financial results